Ionis Pharmaceuticals, Inc. CEO Brett P. Monia Sells 6,630 Shares

IONS Stock  USD 35.90  0.53  1.50%   
Slightly above 62% of all Ionis Pharmaceuticals' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Ionis Pharmaceuticals suggests that some traders are interested. Ionis Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Ionis Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Ionis Pharmaceuticals, Inc. CEO Brett P. Monia sold 6,630 shares of the firms stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of 38.05, for a total value of 252,271.50. Following the transaction, the chief executive officer now owns 167,393 shares in the

Read at thelincolnianonline.com
news
  

Ionis Pharmaceuticals Current Investor Sentiment

Panic Vs Confidence

62

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ionis Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ionis Pharmaceuticals.

Ionis Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ionis Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ionis Pharmaceuticals Historical Investor Sentiment

Investor biases related to Ionis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ionis. The trend in average sentiment can be used to explain how an investor holding Ionis can time the market purely based on public headlines and social activities around Ionis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ionis Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ionis Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ionis Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Ionis Pharmaceuticals.

Ionis Pharmaceuticals Fundamental Analysis

We analyze Ionis Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ionis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ionis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Ionis Pharmaceuticals is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Ionis Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ionis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Ionis Pharmaceuticals Related Equities

TERNTerns Pharmaceuticals   7.82   
0%
100.0%
SRPTSarepta Therapeutics   5.70   
0%
72.0%
APLSApellis Pharmaceuticals   4.63   
0%
59.0%
IOVAIovance Biotherapeutics   3.07   
0%
39.0%
VKTXViking Therapeutics   2.04   
0%
26.0%
HALOHalozyme Therapeutics   1.42   
0%
18.0%
ARWRArrowhead Pharmaceuticals   1.03   
0%
13.0%
INCYIncyte   0.87   
0%
11.0%
BMRNBiomarin Pharmaceutical   0.83   
0%
10.0%
KRYSKrystal Biotech   0.20   
0%
2.0%
ALNYAlnylam Pharmaceuticals   0.15   
0%
1.0%
AKROAkero Therapeutics   0.28   
3.0%
0%
EXELExelixis   1.43   
18.0%
0%
MDGLMadrigal Pharmaceuticals   1.57   
20.0%
0%
PTCTPTC Therapeutics   1.96   
25.0%
0%

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.